Abstract This paper analyzes pharmaceuticalcompany, Merck & Company, INC., . The author provides a company profile and examines a number of issues such as: product marketing, service marketing, manufacturing, values and motives of the company.
From the Paper "The pharmaceutical industry is one of the largest and most far reaching industries in our nation, and therefore is an industry that can neither be avoided nor ignored. The amount of money spent on healthcare is phenomenal ? representing 14 cents of every dollar of goods and services produced in the United States (Jhin, 1996). New drugs that emerged in the past decade proved to be extremely profitable, and with new advances in technology and faster drug approval rates, the outcome is clear ? more money plus better science equals more new drugs (Kleinke, 1998). "
Tags:pharmaceutical, company, health, care, services
Abstract This paper examines the strategic implementation of a marketing strategy for the Walgreen's PharmaceuticalCompany. The author states clear objectives, and discusses products, promotion, services offered, price strategy, and methods of maintaining strategic competence.
Abstract This paper presents a policy statement by the Company, a fictional pharmaceuticalcompany, that discusses concerns and expectations about market conditions in the coming year, which may impact the Company's operations and profitability. It provides a plan that may impact upon future financial and operating performance for the Company. It also looks at threats to the financial stability of the Company.
Table of Contents:
Pounds, Dollar, and Euros: Purchasing Power Parity
US Economy Strength and Expansion of R&D Capacity
German Competitor Introduction of Generic Detervin
Federal Reserve Interest Rates
Inflation Rate in Turkey Expected to be Very High
Price Volatility on the New York Stock Exchange
Interest Rates on Government Bonds in US and Germany
Conclusion
From the Paper "The Company faces several challenges in the coming financial years, including managing subsidiary operations in a volatile and changing environment. The fact that much of the growth potential for the Company is found in its foreign subsidiaries implies that it will have to find ways to finance operations through local avenues increasingly going forward. As the strength of the British pound become diluted closer to historical norms over time, the growth in subsidiaries should allow to the Company to increase both its operating and profit performance. Therefore, the coming year should represent significant opportunities to positively impact future growth with management's efforts to capitalize on market challenges around the world."
Abstract This paper presents an overview of the Wyeth PharmaceuticalsCompany. The paper relates that Wyeth Pharmaceuticals is the globe's biggest pharmaceutical and healthcare company and that it holds the premier position among the 35 pharmaceuticalcompanies present globally for patent based intellectual property. The paper also provides some additional statistics about Wyeth and then discusses the company's financial outcomes, state of competition and strengths. The paper concludes with a discussion on the process of product life cycle management at the company. Financial data about the Wyeth is also included with the paper.
Table of Contents:
Financial Outcomes
The Global Pharmaceutical Scenario and State of Competition
Wyeth's Product Strengths
Unique R&D - Our Core Strength
Learn & Confirm - A New Paradigm
Pharmaceuticals - A Knowledge Driven Industry
Product Life Cycle Management-A Sunrise Business Process for Pharmaceutical Industry
Financial Highlights
Selected Financial Data
Worldwide Net Revenue by Product
From the Paper "In the sphere of consumer healthcare products, our company is a leader in research, development, production, and marketing of wide range of consumer healthcare products running in more than 65 nations. Our sales figures for the year 2006 have touched $2.5 billion, and Wyeth Consumer Healthcare is among the biggest OTC healthcare product in the entire world with workforce strength of 3200. The commitment of our company in improving the healthcare across the world has transformed Wyeth Consumer Healthcare into a top ranked competitor in excess of a dozen vital product categories inclusive of analgesic, cough cold allergy and vitamin/ nutritional supplements."
Abstract This paper addresses several questions concerning the ethical conduct of pharmaceuticalcompanies. The paper considers whether doctors that sit on the boards of companies can be impartial when they make decisions to financially back research/drugs of the pharmaceuticalcompany they represent, as well as what should be the corporate responsibility of the pharmaceuticalcompanies. Also considered is whether pharmaceuticalcompanies have systems in place to keep them ethically responsible and if advertising by pharmaceuticalcompanies actually creates a demand for prescriptions when no need actually exists. Numerous graphs and tables are included.
From the Paper "Indeed, one of the unique aspects of advertising prescription pharmaceuticals is the caveat "Ask your doctor". The consumer cannot go out and directly purchase the product (note that via the internet this is now possible), but traditionally must receive a physician's endorsement by way of a prescription. The pharmaceutical industry uses this reasoning to defend its promotional tactics, claiming that because doctors ultimately authorize prescriptions the public is insulated from deceptive advertising. Yet research indicates that doctors are likely to prescribe drugs patients request under increasing pressure. Patients often insist on brand names over generic drugs, some of which are just as effective and less costly."
Abstract This paper examines how Pfizer is one of the most successful pharmaceuticalcompanies in existence and how much, if not most, of Pfizer's success is due to the corporation's marketing genius, which is considered to be among the best in the industry. It looks at how Pfizer also has one of the best safety records in the industry, which helps in gaining investors and trust in the company. It also explores how, unlike most large corporations, Pfizer draws revenue from a limited number of products.
Outline
Company Structure and Marketing Strategies
Marketing Strengths
Threats
From the Paper "The marketing principles utilized by Pfizer guides every aspect of the corporation's business. There are five main principles that are fundamental to Pfizer's business practices. First, the work conducted by Pfizer is grounded in science. With solid clinical research as a foundation, Pfizer's marketing group uses its credibility and knowledge to develop important relationships within the medical community. Second, Pfizer takes an integrated approach to its marketing strategies. Innovation is promoted through the encouragement of teamwork within and across marketing groups. This also allows Pfizer to respond flexibly and promptly to changes in the market."
Abstract In this article, the writer discusses managing risk in international trade. The paper addresses the matter of the identification of the financial risks of conducting business internationally. The writer examines the significance of foreign exchange rate risk. Further, the writer discusses how this risk can be mitigated.
From the Paper "International trade is an important factor in stimulating growth in the U.S. economy. Most economists agree that international trade and the theories of absolute advantage as well as comparative advantage, as they relate to international trade boost economic growth and improve the standard of living of the average American. However, doing business internationally is not without risk. For example, even if a company opts to export goods rather than to locate business operations in a foreign country, it still faces the possibility that ... "
Abstract The paper is an in-depth, fully comprehensive study on the Shire PharmaceuticalCompany, concentrating on the issues of finance and accounting. Performances of all sections of the company are highlighted and well-illustrated with graphs and tables, which are easy to analyze and understand. An interesting feature of the paper is a FAQ section which addresses issues, particularly relevant to financial management.
Outline:
Introduction
Methodology
Financial accounting
Financial m
Management accounting
From the Paper "For the analysis of the literature gathered, one of the main objectives has to be able to present the analyses in a direct and concise manner, utilizing graphic representations or interpretations to illustrate deductions. Whenever possible, the research referred to expert opinions as the foundation of analyses as well as prevailing opinions posted through internet discussions about Shire, the pharmaceutical industry and trends in the FTSE. Models, summaries or tables derived from independent research were also used to facilitate discussion in the construction of the research as well as in the research documentation itself.
The consolidation of insights regarding Shire was done through a process of collaboration which then followed verification through a review of the primary and secondary literature used at the beginning of the research. The final written paper is designed to informative and comprehensive however there was recognition that the study could not be as exhaustive because of limitations on the length of the paper. This is one of the main challenges for the research: considering the amount of information the research required, significant discretion was to be exercised on what was to be included or excluded in the paper."
Abstract This is an 9-page paper that analyzes the financial position of multinational company by answering various questions. It uses 6 references in MLA format. 9 pgs. Bibliography lists 7 sources.
Abstract The paper proposes to research the effects of applying long-term customer relationships in the pharmaceutical field, by targeting the cities in the Gulf areas and particularly, within the Kuwait market. The paper discusses the competition between the brand name industries and the generic industries and looks at how the governments of the Gulf countries are forced to choose between the two companies. The paper examines the mistrust that has developed because of the irresponsible situations and actions from both the pharmaceuticalcompanies and the governments.
Outline:
Abstract
Introduction
The Research Problem
The Problem Statement
The Research Questions
Research Objectives
Methodology
Operational and Research Methodology
Problems and Limitations
From the Paper "The pharmaceutical industry is a major business worldwide. The largest industry is the weapons industry and the pharmaceutical industry follows right behind the weapons industry. The pharmaceutical industry is the world's second largest business in terms of its products and services. Each year, governments from all over the world spend millions of dollars in order to secure medications, various equipment and other products and services that their countries need in order to help their sick citizens and maintain the health of those who are not sick. In addition to the government's spending on the medication and supplies from large suppliers, there is another competition from within in regards to outside research companies who produce different products that are used for the same ailments. These other research companies are known as the generic industry."
Abstract This paper takes an in depth look at the ways in which pharmaceuticalcompanies unscrupulously put profit before people. Five of the main ways in which they do this that are discussed are; manipulation of research, undue influence over doctors prescribing practices, direct-to-consumer advertising, discrediting of their competitors pharmaceutical and natural alike, and investing only in profitable research. Each topic is discussed thoroughly with credible sources to back the data up.
From the Paper "The pharmaceutical industry wants people to believe that their main goal is to help people. The Pharmaceutical Research and Manufacturers of America (PhRMA) has even begun airing feel-good commercials featuring people whose lives have been saved by medications. In reality, they spend billions of dollars every year to ensure their true purpose, maximum profit. Their influence begins in the research lab, where the sponsor, usually a pharmaceutical company with a huge financial stake in the findings, has more to say over how the study is conducted and what information is released then the actual investigators, leading some of the foremost medical journals in the world to fight back with strict guidelines. After the pharmaceutical companies get their products approved, they engage in a campaign of bribery to persuade doctors to prescribe their name brand, expensive drugs over their competitor's products. Not wanting to leave it up to the doctors alone to endorse their products, the pharmaceutical industry has started advertising directly to an unwitting populace, on television and in popular magazines. Pharmaceutical companies use their political power and vast economic resources to discredit and undermine non-drug treatment options for various diseases, particularly by attacking the burgeoning field of holistic medicine. Furthermore, the pharmaceutical companies have a long history of not investing in research that would lead to drugs for diseases that effect the world's poor, because there is little profit to be made in developing nations. Through various immoral practices, the pharmaceutical companies put profit ahead of the interests, health and safety of consumers. "
Abstract This article researches the Merck Pharmaceuticalcompany. This paper discusses Merck's business decisions in recent years. This paper discusses strategic plans involving changes in the business environment. This paper uses business models and theories to analyze the role of Merck in the pharmaceutical industry.
Tags:pharmaceuticals, Merck, thesis, business, business environment, competition
Abstract This paper analyzes the US medical giant, Pfizer Inc. According to this paper, Pfizer Inc. is one of the leading pharmaceuticalcompanies in the U.S. This paper reviews the company's place in the industry and their stock dividends.
From the Paper "Pfizer is a U.S. based pharmaceutical company, which opened its doors 156 years ago in 1849 with a compound that was proven to take care of parasitic worms. There were two co-founders, Charles Pfizer and his cousin Charles Erhart. Both had come from Germany in the hopes of starting a business together. They had no idea that what they would leave behind would end up being one of the largest pharmaceutical companies in the nation ("Exploring our History", 2005). Industry Analysis Pfizer participates in an industry coded and named by the United States Department of Labor. As such they do business in Division D: Manufacturing - Major Group 28: Chemicals and Allied Products. Specifically Pharmaceutical Preparation coded 2834. Any company in this category produces, manufactures, "fabricates or processed pharmaceutical drugs in preparation for human or veterinary consumption" ("SIC Description for 2834", 2005)."
Abstract This paper examines how globalism affects relations between states and their institutions. The author describes how supranational organizations, such as the International Monetary Fund and the World Bank, endeavor to manage the global economy by controlling the movements of funds between nations and providing financial aid to developing and "transitional" economies. While America's national debt skyrockets, nations such as China and India play the internationalfinance game, manipulating the institutions that govern the world economy for their own benefit, and that of the corporations that operate within their borders. The paper concludes by asking whether this skewed status quo should be allowed to continue or whether there should be a re-alignment to achieve true equity.
From the Paper "The International Monetary Fund and World Bank are major players on the world economic scene. Founded at the end of the Second World War in Bretton Woods, New Hampshire, the International Monetary Fund, or IMF, is a multinational organization that attempts to manage the global financial system through regulation of exchange rates, international trade and exchange payments, and so forth. Originally basing currency exchange on a gold standard, this was effectively dropped by the United States in 1971, in a decision by President Richard Nixon that allowed currencies to float against one another in the market. Since that time, the IMF has concentrated primarily on trying to assist what it terms Lesser Developed Countries (LDC's) and Countries in Transition (CIT's) by lending them money to either stabilize their currency or offset their national debt."
Tags:finance, Third World, dollar commercial deficit budget trade
Abstract In this article, the writer looks at the central bank, which is one of the most important institutions in a country and whose main responsibility is the national monetary policy. The writer notes that many countries can improve the efficiency of their foreign currency reserve by investing the money and generating a return. The writer also points out that, on a global level, the increased efficiency of a central bank's use of reserve would translate into a reduction of financial crises, which would allow institutions such as the International Monetary Fund to redirect its funds to countries that are not yet capable to reach financial stability as well as design policies for those countries targeting their future stability. The writer notes that these are usually third world countries or developing countries with endemic corruption and political instability.
Outline:
The Central Bank - Roles
Reserves Policy - Evidence from Developing Countries
Central Banks and Foreign Currency Reserve Policy Efficiency
From the Paper "A healthy reserve policy can overcome financial crises, such as those related to the country's balance sheet. Korea stands as a good example in this direction with its 1997 crisis. Investment banks started to borrowed short maturity foreign currencies and invested them in Korean won assets after the market deregulation in 1990. The same banks invested in foreign securities Russian bonds and by the end of 1997 the value of these obligations exceeded Korea's foreign currency reserves. In the context of a general fall of Asian currencies, the investors started to sell the Korean won, which eventually devaluated the national currency and forced the authorities to resort to the International Monetary Fund. The problem was not that Korean wasn't solvent, but that it wasn't liquid and this crisis could have been avoided, if the authorities hadn't let the national liquidity deteriorate so much since the beginning of 1990s."
